Pricing Log in Create free account

Edgewise Therapeutics, Inc. (EWTX) vs Tango Therapeutics, Inc. (TNGX)

Edgewise Therapeutics, Inc. and Tango Therapeutics, Inc. are both Biotechnology companies. Edgewise Therapeutics, Inc. is the larger, with a market value of $4.2B against $3.5B — 1.2× the size. Tango Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Edgewise Therapeutics, Inc. trades at 4.9×. Across the 10 metrics below, Edgewise Therapeutics, Inc. leads on 7 and Tango Therapeutics, Inc. on 3.

Valuation

Metric EWTX TNGX Biotechnology median
P/E 4.85 n/m 10.60
P/S n/m 51.65 9.40
P/B 2.99 3.15 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 35.40 9.02
Earnings yield 20.61% (3.91%) (32.88%)
Free cash flow yield (4.14%) (4.48%) (23.13%)

Profitability

Metric EWTX TNGX Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 92.15% (21.34%) (51.96%)
Return on assets 85.43% (18.86%) (46.06%)
Return on invested capital 0.00% (808.35%) 0.00%

Growth

Metric EWTX TNGX Biotechnology median
Revenue growth (TTM) — 48.29% 6.76%
EPS growth (last fiscal year) (12.41%) 26.89% 29.88%
Revenue growth, 5-year CAGR — 52.13% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EWTX TNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.30 50.82 4.97
Net debt to EBITDA 2.69 3.08 1.01

Dividend

Metric EWTX TNGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EWTX TNGX Biotechnology median
Market cap 4.22b 3.52b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack